Nothing Special   »   [go: up one dir, main page]

MX2019011901A - Metodo para preparar y analizar compuestos fluorescentes en plasma. - Google Patents

Metodo para preparar y analizar compuestos fluorescentes en plasma.

Info

Publication number
MX2019011901A
MX2019011901A MX2019011901A MX2019011901A MX2019011901A MX 2019011901 A MX2019011901 A MX 2019011901A MX 2019011901 A MX2019011901 A MX 2019011901A MX 2019011901 A MX2019011901 A MX 2019011901A MX 2019011901 A MX2019011901 A MX 2019011901A
Authority
MX
Mexico
Prior art keywords
plasma
sample
preparing
analyzing
fluorescent compounds
Prior art date
Application number
MX2019011901A
Other languages
English (en)
Inventor
J Shieh Jeng
Original Assignee
Medibeacon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medibeacon Inc filed Critical Medibeacon Inc
Publication of MX2019011901A publication Critical patent/MX2019011901A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/74—Optical detectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/16—Injection
    • G01N30/22—Injection in high pressure liquid systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/06—Preparation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/06—Preparation
    • G01N30/14—Preparation by elimination of some components
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D229/00—Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/38—Diluting, dispersing or mixing samples
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8822—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/884—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Fluid Mechanics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se describe aquí un método para analizar la concentración de un compuesto fluorescente en el plasma de un paciente. El método incluye recolectar una muestra de plasma de un paciente, diluir la muestra con un solvente y analizar la muestra diluida mediante HPLC. La muestra no necesita dejarse secar durante la preparación de muestras, ni se requiere un estándar interno.
MX2019011901A 2017-11-20 2018-11-15 Metodo para preparar y analizar compuestos fluorescentes en plasma. MX2019011901A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762588606P 2017-11-20 2017-11-20
PCT/US2018/061282 WO2019099672A1 (en) 2017-11-20 2018-11-15 Method for preparing and analyzing fluorescent compounds in plasma

Publications (1)

Publication Number Publication Date
MX2019011901A true MX2019011901A (es) 2019-12-05

Family

ID=66532776

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019011901A MX2019011901A (es) 2017-11-20 2018-11-15 Metodo para preparar y analizar compuestos fluorescentes en plasma.

Country Status (16)

Country Link
US (1) US11674965B2 (es)
EP (1) EP3713577A4 (es)
JP (1) JP2020516692A (es)
KR (2) KR20220021024A (es)
CN (1) CN110461332A (es)
AU (1) AU2018369913B2 (es)
BR (1) BR112019021044A2 (es)
CA (1) CA3058762A1 (es)
IL (1) IL269611A (es)
MX (1) MX2019011901A (es)
MY (1) MY188418A (es)
PH (1) PH12019502373A1 (es)
RU (1) RU2746503C1 (es)
SG (1) SG11201909366XA (es)
WO (1) WO2019099672A1 (es)
ZA (1) ZA201906445B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113109491A (zh) * 2020-01-13 2021-07-13 四川基因格司法鉴定中心 从生物样本中检测毒药物的通用方法
TW202233586A (zh) * 2020-11-10 2022-09-01 美商麥迪貝肯有限公司 吡𠯤化合物的皮下與肌內注射
JP2024512924A (ja) * 2021-03-31 2024-03-21 メディビーコン，インク． 置換ジアミノピラジンジカルボン酸の調製
JP2024512916A (ja) * 2021-03-31 2024-03-21 メディビーコン，インク． 置換ジアミノピラジンジカルボン酸の精製
CN117769543A (zh) * 2021-08-11 2024-03-26 杭州中美华东制药有限公司 制备作为荧光示踪剂的吡嗪羧酸类衍生物的方法
WO2023025271A1 (zh) * 2021-08-27 2023-03-02 杭州中美华东制药有限公司 吡嗪类衍生物的晶型及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4647742B2 (ja) * 2000-03-13 2011-03-09 三菱化学メディエンス株式会社 アスコルビン酸の分析方法及び分析用試薬
US6969592B2 (en) * 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy
US6909912B2 (en) 2002-06-20 2005-06-21 University Of Florida Non-invasive perfusion monitor and system, specially configured oximeter probes, methods of using same, and covers for probes
EP1620002B1 (en) 2003-04-24 2012-01-04 The Board Of Regents, The University Of Texas System Noninvasive blood analysis by optical probing of the veins under the tongue
US20060095102A1 (en) 2003-09-17 2006-05-04 Thomas Perez Method and apparatus for sublingual application of light to blood
JP4214109B2 (ja) * 2004-12-16 2009-01-28 日本ハム株式会社 畜水産物中の残留動物用薬剤の抽出液
CN101812027A (zh) 2004-12-23 2010-08-25 马林克罗特公司 荧光吡嗪衍生物及其在评估肾功能中的使用方法
DK2029554T3 (da) 2006-06-22 2014-06-10 Medibeacon Llc Pyrazinderivater og anvendelser heraf til nyreovervågning
EP3461503B9 (en) * 2007-04-11 2022-05-11 BioMarin Pharmaceutical Inc. Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
WO2011104238A1 (en) 2010-02-23 2011-09-01 B.R.A.H.M.S Gmbh A method for determining a marker in small volume of a sample of a bodily fluid
US20120172678A1 (en) 2010-12-30 2012-07-05 Logan Robert J Systems and methods for monitoring and processing biometric data
AU2012249600B2 (en) 2011-04-26 2016-05-19 Incube Labs, Llc Mouthpiece for measurement of biometric data of a diver and underwater communication
EP3294296A4 (en) 2015-05-12 2018-12-26 Medibeacon Inc. Compositions and methods for assessing eye vasculature

Also Published As

Publication number Publication date
US11674965B2 (en) 2023-06-13
WO2019099672A1 (en) 2019-05-23
RU2746503C1 (ru) 2021-04-14
KR20200007778A (ko) 2020-01-22
IL269611A (en) 2019-11-28
EP3713577A1 (en) 2020-09-30
AU2018369913A1 (en) 2019-10-17
AU2018369913B2 (en) 2020-08-20
PH12019502373A1 (en) 2020-07-13
US20190154697A1 (en) 2019-05-23
EP3713577A4 (en) 2021-08-18
CA3058762A1 (en) 2019-05-23
CN110461332A (zh) 2019-11-15
SG11201909366XA (en) 2019-11-28
ZA201906445B (en) 2020-08-26
JP2020516692A (ja) 2020-06-11
KR20220021024A (ko) 2022-02-21
MY188418A (en) 2021-12-08
BR112019021044A2 (pt) 2020-05-12

Similar Documents

Publication Publication Date Title
PH12019502373A1 (en) Method for preparing and analyzing fluorescent compounds in plasma
MX2018002483A (es) Equipos y métodos novedosos para detectar trastornos de ciclo de urea que usan espectrometría de masas.
MX2017015229A (es) Metodos para la cuantificacion espectrometrica de masas de analitos extraidos de un dispositivo de micromuestreo.
EP3341724A4 (en) DEVICE AND SYSTEM FOR DETECTING AND ANALYZING STEAM CONDENSATE, ESPECIALLY EXTRACTED ATOMIC CONDENSATE, AND METHOD FOR USE THEREOF
EP3502669A4 (en) ORGANIC COMPOUND ANALYZER, ORGANIC COMPOUND ANALYZING METHOD AND PROGRAM FOR AN ORGANIC COMPOUND ANALYZER
EP3341728A4 (en) DEVICE AND SYSTEM FOR ANALYZING A SAMPLE, PARTICULARLY BLOOD AND METHODS OF USING SAME
EA201791390A1 (ru) Способ получения соединения диарилтиогидантоина
EP3269849A4 (en) POROUS COMPOUND MONOCRYSTAL, PROCESS FOR EVALUATING MONOCRYSTAL QUALITY, PROCESS FOR PREPARING SOLUTION COMPRISING COMPOUND FOR ANALYZING, PROCESS FOR PRODUCING CRYSTALLINE STRUCTURE ANALYSIS SAMPLE, AND PROCESS FOR DETERMINING MOLECULAR STRUCTURE OF COMPOUND ANALYZE
EP4273523A3 (en) Plasma-based optical emission method for detecting impurities in a gas
BR112013015504A2 (pt) dispositivo de amostragem para um espectrômetro de migração de íon, método para introduzir uma amostra de gás a ser detectada pelo uso do dispositivo, e, espectrômetro de migração de íon
MX2015014475A (es) Dispositivo de transferencia de muestras de sangre y sistema de separacion y analisis de sangre.
MY187050A (en) Cancer cell-specific antibody, anticancer agent, and cancer testing method
EA201690718A1 (ru) Способ обработки целлюлозосодержащей биомассы
PH12017500213A1 (en) Methods and compositions for analyzing glucose-6-phosphate dehydrogenase activity in blood samples
BR112015016228A8 (pt) método e aparelho para estimar parâmetro de interesse a partir de espectro de raios gama de amostras de referência
IL291325A (en) Anti-klk7 antibodies, anti-klk5 antibodies, multispecific anti-klk5/klk7 antibodies and methods of use
MX2019002818A (es) Metodos para detectar anticuerpos neutralizantes anti-leptina.
MX356023B (es) Metodo y aparato para corregir desviaciones de intensidad en un espectrometro.
EP3443338A4 (en) METHODS OF DETECTING SAMPLE ENANTIOMERS USING DIFFERENTIAL MOBILITY SPECTROMETRY
EP3073259A3 (en) Absorption mode ft-ims
GB201216282D0 (en) Method and apparatus for identifying regions of interest in medical imaging data
EA201790975A1 (ru) Способы извлечения спиртов
EP3401686A4 (en) BLOOD COLLECTION TUBES, REAGENTS AND METHOD FOR ANALYZING BLOOD FEATURES THEREFORE
EP3696529A4 (en) METHOD OF QUANTITATIVE ANALYSIS OF POLYMER USING MALDI MASS SPECTROMETRY AND METHOD OF PREPARING A SAMPLE FOR MALDI MASS SPECTROMETRY FOR QUANTITATIVE POLYMER ANALYSIS
EP3149461A4 (en) Active, variable sample concentration method and apparatus for sub-ppb measurements and exemplary x-ray analysis applications thereof